- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Alkermes PLC+ Add to Watchlist
ALKS:US39.8500 USD 0.0100 0.03%
As of 20:10:00 ET on 12/06/2013.
Company Profile for Alkermes PLC (ALKS)
Alkermes PLC researches pharmaceuticals. The Company develops treatments for central nervous system disorders such as addiction, schizophrenia and depression, and diabetes.
Key Executives for Alkermes PLC (ALKS)
|Richard F PopsChairman/CEO||Shane CookePresident|
|James M Frates "Jim"Senior VP/CFO||Gordon G PughSenior VP/COO/Chief Risk Ofcr|
|Mark StejbachSenior VP/Chief Commercial Ofcr||Kathryn L BibersteinSenior VP/Secy/General Counsel|
|Michael J Landine "Mike"Senior VP:Corporate Development||Srdjan Stankovic "Serge"Senior VP:Clinical Dev & Medical Affairs|
|Elliot W EhrichSenior VP:R&D/Chief Medical Officer|